Acta Pharmaceutica, Vol. 59 No. 1, 2009.
Kratko priopćenje
https://doi.org/10.2478/v10007-009-0009-8
Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals
AMANY HASSAN M. EL SHAZLY
; Department of Pharmacology, Research Institute of Ophthalmology, Giza, Egypt
ATEF MOHAMED MAHMOUD
; Department of Biochemistry, Research Institute of Ophthalmology, Giza, Egypt
NEVINE SALAH DARWISH
; Department of Histology, Research Institute of Ophthalmology, Giza, Egypt
Sažetak
This study sought to determine the potential prophylactic and antioxidant effects of aminoguanidine in experimentally induced diabetes. Four groups of Wistar rats, each composed of ten rats, were used. Two groups served as control. In group 3, diabetes was induced by a single intraperitoneal injection of streptozotocin (65 mg kg1). In group 4, diabetes was induced and treated with aminoguanidine 100 mg kg1 daily orally for 3 months. Levels of serum glucose, glutathione peroxidase, glutathione reductase and erythrocytes catalase were analyzed on day 90 of the experiment. Retinal and kidney specimens were examined histopathologically after sacrifice of the animals. A significant antioxidant effect of aminoguanidine and its prophylactic role in diabetic retinopathy and nephropathy were observed in experimental animals.
Ključne riječi
aminoguanidine; diabetic retinopathy; nephropathy; nitric oxide; glycated end product; antioxidants
Hrčak ID:
32297
URI
Datum izdavanja:
1.3.2009.
Posjeta: 2.482 *